Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. (SHE:301617)

Market Cap	4.92B
Revenue (ttm)	1.34B
Net Income (ttm)	211.06M
Shares Out	102.80M
EPS (ttm)	2.52
PE Ratio	18.95
Forward PE	n/a
Dividend	0.60 (1.25%)
Ex-Dividend Date	Jan 24, 2025

Volume	641,090
Average Volume	1,298,611
Open	48.14
Previous Close	47.34
Day's Range	47.44 - 48.14
52-Week Range	41.38 - 107.66
Beta	n/a
RSI	50.33
Earnings Date	May 19, 2025

About SHE:301617

Shandong Boyuan Pharmaceutical & Chemical Co., Ltd. engages in the research and development, production, and sales of fine chemicals. The company offers iodine derivatives, such as potassium iodide, sodium iodide, potassium iodide, hydriodic acid, copper iodide, and iodotrimethylsilane; and fine chemicals, including hexamethyldisilazane, hexamethyldisilane, hexamethyldisiloxane, and tris[2-(2-methoxyethoxy)ethyl]amine. It also offers chemiluminescent products comprising 3,5-Dichlorosalicylic acid; 3,5,6-Trichlorosalicylic acid; bis(2,4,5-trichl...

• Industry: Industrial Inorganic Chemicals
• Founded: 2008
• Country: China
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 301617

Financial Performance

In 2024, SHE:301617's revenue was 1.33 billion, an increase of 29.53% compared to the previous year's 1.03 billion. Earnings were 213.13 million, an increase of 17.04%.